These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 10889865)

  • 1. Hereditary breast cancer. Psychosocial issues and family physicians' role.
    Carroll JC; Heisey RE; Warner E; Goel V; McCready DR
    Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.
    Warner E; Heisey RE; Goel V; Carroll JC; McCready DR
    Can Fam Physician; 1999 Jan; 45():104-12. PubMed ID: 10889863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ; ten Kroode HF; Ausems MG
    Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
    Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial ovarian cancer.
    Elit L
    Can Fam Physician; 2001 Apr; 47():778-84. PubMed ID: 11340759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
    Sherman KA; Kasparian NA; Mireskandari S
    Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do physicians discuss genetic testing with family-history-positive breast cancer patients?
    Polednak AP
    Conn Med; 1998 Jan; 62(1):3-7. PubMed ID: 9509706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.
    Hopwood P; Keeling F; Long A; Pool C; Evans G; Howell A
    Psychooncology; 1998; 7(5):402-12. PubMed ID: 9809331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dispositional optimism predict psychological responses to counseling for familial breast cancer?
    Norman P; Brain K
    J Psychosom Res; 2007 Sep; 63(3):247-54. PubMed ID: 17719361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.